PMID- 36631451 OWN - NLM STAT- MEDLINE DCOM- 20230210 LR - 20230215 IS - 2158-3188 (Electronic) IS - 2158-3188 (Linking) VI - 13 IP - 1 DP - 2023 Jan 12 TI - Serum complement proteins rather than inflammatory factors is effective in predicting psychosis in individuals at clinical high risk. PG - 9 LID - 10.1038/s41398-022-02305-1 [doi] LID - 9 AB - Immunological/inflammatory factors are implicated in the development of psychosis. Complement is a key driver of inflammation; however, it remains unknown which factor is better at predicting the onset of psychosis. This study aimed to compare the alteration and predictive performance of inflammation and complement in individuals at clinical high risk (CHR). We enrolled 49 individuals at CHR and 26 healthy controls (HCs). Twenty-five patients at CHR had converted to psychosis (converter) by the 3-year follow-up. Inflammatory cytokines, including interleukin (IL)-1beta, 6, 8, 10, tumor necrosis factor-alpha (TNF-alpha), macrophage colony-stimulating factor levels, and complement proteins (C1q, C2, C3, C3b, C4, C4b, C5, C5a, factor B, D, I, H) were measured by enzyme-linked immunosorbent assay at baseline. Except for TNF- alpha, none of the inflammatory cytokines reached a significant level in either the comparison of CHR individuals and HC or between CHR-converters and non-converters. The C5, C3, D, I, and H levels were significantly lower (C5, p = 0.006; C3, p = 0.009; D, p = 0.026; I, p = 0.016; H, p = 0.019) in the CHR group than in the HC group. Compared to non-converters, converters had significantly lower levels of C5 (p = 0.012) and C5a (p = 0.007). None of the inflammatory factors, but many complement factors, showed significant correlations with changes in general function and symptoms. None of the inflammatory markers, except for C5a and C5, were significant in the discrimination of conversion outcomes in CHR individuals. Our results suggest that altered complement levels in the CHR population are more associated with conversion to psychosis than inflammatory factors. Therefore, an activated complement system may precede the first-episode of psychosis and contribute to neurological pathogenesis at the CHR stage. CI - (c) 2023. The Author(s). FAU - Zhang, TianHong AU - Zhang T AUID- ORCID: 0000-0002-5379-7119 AD - Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai Intelligent Psychological Evaluation and Intervention Engineering Technology Research Center (20DZ2253800), Shanghai Key Laboratory of Psychotic Disorders, Shanghai, 200030, PR China. zhang_tianhong@126.com. FAU - Zeng, JiaHui AU - Zeng J AD - Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai Intelligent Psychological Evaluation and Intervention Engineering Technology Research Center (20DZ2253800), Shanghai Key Laboratory of Psychotic Disorders, Shanghai, 200030, PR China. FAU - Ye, JiaYi AU - Ye J AD - Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai Intelligent Psychological Evaluation and Intervention Engineering Technology Research Center (20DZ2253800), Shanghai Key Laboratory of Psychotic Disorders, Shanghai, 200030, PR China. FAU - Gao, YuQing AU - Gao Y AD - Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai Intelligent Psychological Evaluation and Intervention Engineering Technology Research Center (20DZ2253800), Shanghai Key Laboratory of Psychotic Disorders, Shanghai, 200030, PR China. FAU - Hu, YeGang AU - Hu Y AD - Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai Intelligent Psychological Evaluation and Intervention Engineering Technology Research Center (20DZ2253800), Shanghai Key Laboratory of Psychotic Disorders, Shanghai, 200030, PR China. FAU - Xu, LiHua AU - Xu L AD - Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai Intelligent Psychological Evaluation and Intervention Engineering Technology Research Center (20DZ2253800), Shanghai Key Laboratory of Psychotic Disorders, Shanghai, 200030, PR China. FAU - Wei, YanYan AU - Wei Y AD - Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai Intelligent Psychological Evaluation and Intervention Engineering Technology Research Center (20DZ2253800), Shanghai Key Laboratory of Psychotic Disorders, Shanghai, 200030, PR China. FAU - Tang, XiaoChen AU - Tang X AD - Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai Intelligent Psychological Evaluation and Intervention Engineering Technology Research Center (20DZ2253800), Shanghai Key Laboratory of Psychotic Disorders, Shanghai, 200030, PR China. FAU - Liu, HaiChun AU - Liu H AD - Department of Automation, Shanghai Jiao Tong University, Shanghai, 200240, PR China. FAU - Chen, Tao AU - Chen T AD - Department of Automation, Shanghai Jiao Tong University, Shanghai, 200240, PR China. AD - Big Data Research Lab, University of Waterloo, Waterloo, ON, Canada. AD - Labor and Worklife Program, Harvard University, Cambridge, MA, USA. FAU - Li, ChunBo AU - Li C AD - Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai Intelligent Psychological Evaluation and Intervention Engineering Technology Research Center (20DZ2253800), Shanghai Key Laboratory of Psychotic Disorders, Shanghai, 200030, PR China. FAU - Wan, ChunLing AU - Wan C AD - Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Bio-X Center, Shanghai Jiao Tong University, Shanghai, PR China. FAU - Wang, JiJun AU - Wang J AUID- ORCID: 0000-0001-5427-7425 AD - Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai Intelligent Psychological Evaluation and Intervention Engineering Technology Research Center (20DZ2253800), Shanghai Key Laboratory of Psychotic Disorders, Shanghai, 200030, PR China. jijunwang27@163.com. AD - Center for Excellence in Brain Science and Intelligence Technology (CEBSIT), Chinese Academy of Science, Beijing, PR China. jijunwang27@163.com. AD - Brain Science and Technology Research Center, Shanghai Jiao Tong University, Shanghai, PR China. jijunwang27@163.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20230112 PL - United States TA - Transl Psychiatry JT - Translational psychiatry JID - 101562664 RN - 0 (Cytokines) RN - 0 (Tumor Necrosis Factor-alpha) RN - 9007-36-7 (Complement System Proteins) RN - 80295-33-6 (Complement C1q) RN - 80295-43-8 (Complement C3b) RN - 80295-50-7 (Complement C4b) RN - 80295-55-2 (Complement C5b) SB - IM MH - Humans MH - Cytokines/blood/chemistry MH - Inflammation/metabolism MH - *Psychotic Disorders/blood/diagnosis MH - Risk Factors MH - Tumor Necrosis Factor-alpha MH - *Complement System Proteins/chemistry MH - Complement C1q/chemistry MH - Complement C3b/chemistry MH - Complement C4b/chemistry MH - Complement C5b/chemistry PMC - PMC9834035 COIS- The authors declare no competing interests. EDAT- 2023/01/12 06:00 MHDA- 2023/01/14 06:00 PMCR- 2023/01/12 CRDT- 2023/01/11 23:13 PHST- 2022/09/12 00:00 [received] PHST- 2022/12/30 00:00 [accepted] PHST- 2022/12/16 00:00 [revised] PHST- 2023/01/11 23:13 [entrez] PHST- 2023/01/12 06:00 [pubmed] PHST- 2023/01/14 06:00 [medline] PHST- 2023/01/12 00:00 [pmc-release] AID - 10.1038/s41398-022-02305-1 [pii] AID - 2305 [pii] AID - 10.1038/s41398-022-02305-1 [doi] PST - epublish SO - Transl Psychiatry. 2023 Jan 12;13(1):9. doi: 10.1038/s41398-022-02305-1.